SCHEMBL21696078

SCHEMBL21696078

Cc1c(C(=O)NC2CCC2)cc(-c2cc(C(C)(C)O)cc(C(F)(F)F)c2)n1CC1CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.52
RORC P51449 2/20 0.51
ALDH1A1 P00352 5/20 0.45
HTT P42858 2/20 0.45
LMNA P02545 2/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
CRHBP P24387 1/20 0.45
KMT2A Q03164 1/20 0.45
CRHR2 Q13324 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
HTR2A P28223 3/20 0.40
HTR2C P28335 3/20 0.40
SLC6A4 P31645 3/20 0.40
CRHR1 P34998 5/20 0.40
TRPV1 Q8NER1 1/20 0.40
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3929705 0.94 CNR1 (0.56) CNR1RORCALDH1A1HTTLMNA
SCHEMBL21696206 0.94 RORC (0.54) CNR1RORCALDH1A1HTTLMNA
SCHEMBL15001567 0.93 RORC (0.60) CNR1RORCALDH1A1HTTLMNA
SCHEMBL3921347 0.93 CNR1 (0.54) CNR1RORCALDH1A1HTTLMNA
SCHEMBL16261327 0.91 RORC (0.55) CNR1RORCALDH1A1HTTLMNA
SCHEMBL16259834 0.89 CNR1 (0.48) CNR1RORCALDH1A1HTTLMNA
SCHEMBL14999538 0.86 RORC (0.51) CNR1RORCALDH1A1HTTLMNA
SCHEMBL15001615 0.86 RORC (0.54) CNR1RORCALDH1A1HTTLMNA
SCHEMBL15001609 0.85 CNR1 (0.45) CNR1RORCHTR2AHTR2CSLC6A4
SCHEMBL21696220 0.85 CNR1 (0.50) CNR1RORCALDH1A1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2800745-B1 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORY, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES PHENEX PHARMACEUTICALS AG (DE) 2020-02-12 EP disclosed